APRE vs NDSN · $10.4M cap vs P/E 31, rev $2.23B
Aprea Therapeutics Inc (APRE) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
APRE does not have a complete income-statement cache yet.
Latest reported NDSN revenue for 2026-07-31 was $2.23B. Net income was $403.5M. Revenue was up 58.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
APRE currently screens at market cap $10.4M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the APRE and NDSN stock pages for the full models.
Not investment advice.